Abstract
Currently, the antigen specificity of Epstein-Barr virus (EBV)-specific cytotoxic T cells (CTLs) can be determined using a set of recombinant vaccinia viruses expressing individual EBV proteins. These recombinant viruses are used to infect EBV-negative target cells, which are then tested for recognition by CTLs in standard cytotoxicity assay. Autologous fibroblasts are the most frequently used target cells for this type of experiment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murray, R. J., Kurilla, M. G., Griffin, H. M., Brooks, J. M., Mackett, M., Arrand, J. R., et al. (1990) Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated using recombinant Vaccinia viruses. Proc. Natl. Acad. Sci. USA 87, 2906–2910.
Hirs, C. and Timasheff, S. (1977) Methods of peptide synthesis, in Enzyme Structure, vol. XLVII (Hirs, C. H. W. and Timesheff, S. N., eds.), Academic, New York, pp. 501–617.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Levitsky, V., Frisan, T., Masucci, M. (2001). Determination of Antigen and Fine Peptide Specificity of EBV-Specific CTLs. In: Wilson, J.B., May, G.H.W. (eds) Epstein-Barr Virus Protocols. Methods in Molecular Biology™, vol 174. Humana Press. https://doi.org/10.1385/1-59259-227-9:209
Download citation
DOI: https://doi.org/10.1385/1-59259-227-9:209
Publisher Name: Humana Press
Print ISBN: 978-0-89603-690-1
Online ISBN: 978-1-59259-227-2
eBook Packages: Springer Protocols